BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29150489)

  • 21. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years' experience in a patient cohort from a defined population area.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    Scand J Gastroenterol; 2005 Sep; 40(9):1076-80. PubMed ID: 16211714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines.
    Mooiweer E; van der Meulen AE; van Bodegraven AA; Jansen JM; Mahmmod N; Nijsten J; van Oijen MG; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013 Nov; 19(12):2603-10. PubMed ID: 24030524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population.
    Kishikawa J; Hata K; Kazama S; Anzai H; Shinagawa T; Murono K; Kaneko M; Sasaki K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Morikawa T; Fukayama M; Watanabe T
    Dig Endosc; 2018 Mar; 30(2):236-244. PubMed ID: 28836702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysplasia in ulcerative colitis--clinical consequences?
    Sjöqvist U
    Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic factors affect the occurrence of colorectal neoplasm on surveillance colonoscopies.
    So H; Han S; Park HW; Kim EH; Lee JY; Lee HS; Chang HS; Kim HK; Choe J; Park SH; Yang DH; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1273-9. PubMed ID: 26729234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
    Goldstone R; Itzkowitz S; Harpaz N; Ullman T
    Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
    Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis.
    Rabbenou W; Ullman TA
    Gastroenterol Clin North Am; 2020 Dec; 49(4):791-807. PubMed ID: 33121696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
    Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
    United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years' Experience in a Patient Cohort from a Defined Population Area.
    Rutegård M; Palmqvist R; Stenling R; Lindberg J; Rutegård J
    Scand J Surg; 2017 Jun; 106(2):133-138. PubMed ID: 27431978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.
    Lakatos L; Mester G; Erdelyi Z; David G; Pandur T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Inflamm Bowel Dis; 2006 Mar; 12(3):205-11. PubMed ID: 16534422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal neoplasia in long-standing ulcerative colitis - a prospective study from a low-prevalence area.
    Shivakumar BM; Lakshmankumar B; Rao L; Bhat G; Suvarna D; Pai CG
    Colorectal Dis; 2013 Aug; 15(8):e462-8. PubMed ID: 23663532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis.
    Flores BM; O'Connor A; Moss AC
    Gastrointest Endosc; 2017 Dec; 86(6):1006-1011.e8. PubMed ID: 28750838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance programmes for neoplasia in colitis.
    Rutter MD
    J Gastroenterol; 2011 Jan; 46 Suppl 1():1-5. PubMed ID: 20798970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study.
    Karlén P; Kornfeld D; Broström O; Löfberg R; Persson PG; Ekbom A
    Gut; 1998 May; 42(5):711-4. PubMed ID: 9659169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.